Mindie H. Nguyen MDProfessor of Medicine (Gastroenterology & Hepatology) and Professor of Epidemiology & Population Health (By Courtesy), Stanford University Medical Center, Palo Alto, California
Dr. Mindie H. Nguyen is Professor of Medicine, and by courtesy, Professor of Epidemiology and Population Health, Director for the Hepatology Fellowship, Director for the Hepatology Clerkship, a Member of the Appointment and Promotion Committee, and a Diversity Advisor for the Department of Medicine at Stanford University Medical Center. She is an active clinician and researcher in viral hepatitis, NAFLD, and liver cancer with over 200 original research publications including first or senior authorship in The New England Journal of Medicine, Lancet Gastroenterology and Hepatology, Gastroenterology, Journal of Hepatology, Hepatology, and JAMA NO. She has served as editorial/advisory board member for major journals such as Lancet Gastroenterology and Hepatology, Gastroenterology, and Hepatology. She has also served as Chair of the Hepatitis B SIG for the AASLD, Officer for the International Association for the Study of Liver Disease, and is active in global health as a Faculty Fellow at the Stanford Center for Innovation in Global Health. She is an active educator and has mentored over 130 trainees from high-school students to undergraduate, medical, Masters/PhD students in Public Health/Epidemiology, clinical residents/fellows, postdoctoral research fellows, and faculty at Assistant/Associate Professor rank.
Dr. Mindie H. Nguyen has received research support from Pfizer, Gilead Sciences, Janssen Pharmaceutical, B. K. Kee Foundation and the National Cancer Institute and has served as an advisory board member or consultant for Dynavax, Gilead, Intercept, Alnylam, Bristol-Myers Squibb, Novartis, Eisai, Bayer, Exact Science, Laboratory of Advanced Medicine, Spring Bank, and Janssen.